CClinicalTrials.gg
CompletedNCT06294938Updated Mar 6, 2024

Glycemic Index of Cacao Fruit Pulp in Healthy, Human Subjects

An interventional study of Cacao fruit pulp and Dextrose in Blood Sugar; High and Blood Sugar; Low, sponsored by Mars Wrigley. Completed at 1 site in Canada. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-06.

Sponsored by Mars Wrigley · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Sep 2022, registered Jan 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Cacao fruit pulp is a sweet and fruity carbohydrate-rich edible mucilage that is often discarded. The objective of this study is to assess the glycemic response and determine the glycemic index of cacao fruit pulp.

Read the detailed description

In an acute, open-labeled, randomized design, individuals without diabetes were studied over 120 minutes after consuming 25 grams of available carbohydrate portions of cacao pulp or dextrose.

02

Conditions studied

  • Blood Sugar; High
  • Blood Sugar; Low

Browse trials for

03

In context

Hyperglycemia

699 studies on the registry are indexed under Hyperglycemia; 105 are open to participants now.

This study's enrollment of 10 is below the median of 46 across 521 interventional studies indexed under Hyperglycemia.

Browse Hyperglycemia studies →

Lead sponsor

Mars Wrigley is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: Subjects were males or non-pregnant females and in good health.

Exclusion Criteria: Subjects with a known history of AIDS, hepatitis, diabetes or a heart condition. Subjects taking medication or with any condition that might make participation dangerous to the subject, to others, or affect the results.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
10 participants (actual)

Study arms

  • Active comparator
    Dextrose

    Dextrose matched for available carbohydrate

    Other: Dextrose

  • Experimental
    Cacao fruit pulp

    Cacao fruit pulp matched for available carbohydrate

    Other: Cacao fruit pulp

Interventions

  • OtherCacao fruit pulp

    Cacao pulp puree

  • OtherDextrose

    Dextrose beverage

06

What researchers measure

Primary outcomes

  1. Plasma Glucose

    Mean plasma glucose

    Time frame: 1-120 minutes

  2. Incremental area under the curve

    Calculated from mean plasma glucose

    Time frame: 1-120 minutes

  3. Peak plasma glucose

    Peak plasma glucose (Cmax)

    Time frame: 1-120 minutes

07

Study locations

1 site
  • INQUIS Clinical Research
    Toronto, Onterio M5C 2N8, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06294938
Lead sponsor
Mars Wrigley
Collaborators
INQUIS Clinical Research
Responsible party
Sponsor
First posted
Mar 6, 2024
Start date
Sep 30, 2022
Primary completion
Jan 24, 2023
Completion
May 23, 2023
Last update
Mar 6, 2024

Study contacts

Thomas Wolever, MD, PhD
principal investigator · INQUIS Clinical Research

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion